{
    "clinical_study": {
        "@rank": "147946", 
        "acronym": "ASSIST-K", 
        "brief_summary": {
            "textblock": "There is paucity of information about the combination therapy with dipeptidyl peptidase-4\n      inhibitor sitagliptin and insulin. This study aimed to retrospectively investigate the\n      safety and efficacy of this therapeutic modality in Japanese patients with type 2 diabetes."
        }, 
        "brief_title": "Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes", 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  outpatients with type 2 diabetes\n\n          -  addition of sitagliptin to insulin therapy\n\n          -  aged 20 years or older\n\n          -  HbA1c of 6.9% or higher (NGSP) at the time of adding sitagliptin\n\n        Exclusion Criteria:\n\n          -  history of hypersensitivity to sitagliptin\n\n          -  severe ketosis, diabetic coma, and/or precoma within 6 months before sitagliptin\n             administration\n\n          -  sever infection and/or severe trauma, and/or patients who are scheduled to undergo /\n             have recently underwent surgery\n\n          -  severe renal dysfunction (serum creatinine [mg/dL]: 2.5 or higher for men; 2.0 or\n             higher for women)\n\n          -  ongoing treatment with glinide(s)\n\n          -  judgment as ineligible for the study by the attending physician"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "One-thousand Japanese patients with type 2 diabetes"
            }
        }, 
        "firstreceived_date": "May 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01855087", 
            "org_study_id": "R875"
        }, 
        "intervention_browse": {
            "mesh_term": "Sitagliptin"
        }, 
        "lastchanged_date": "May 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kamakura", 
                    "country": "Japan", 
                    "state": "Kanagawa", 
                    "zip": "247-0056"
                }, 
                "name": "Takai Naika Clinic"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Study of Safety and Efficacy of Sitagliptin Added to Insulin Therapy in the Treatment of Type 2 Diabetes in Kanagawa", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Ethical Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Blood glucose level", 
            "time_frame": "Six months after starting sitagliptin-insulin combination therapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01855087"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kanagawa Physicians Association", 
            "investigator_full_name": "Ikuro Matsuba", 
            "investigator_title": "Chairperson", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Kanagawa Physicians Association", 
        "sponsors": {
            "collaborator": {
                "agency": "The Kidney Foundation, Japan", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Kanagawa Physicians Association", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}